trial

Antipsychotic Therapy and First Episode

NCTId NCT00334035
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 4 · Completed
Enrollment 169 (actual)
Sponsored by The University of Hong Kong
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 4
Status
Completed
Enrollment
169 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2003-08
Primary completion
—
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Quetiapine

Sponsors

The University of Hong KongLead Sponsor

Investigators

1
Eric Yu Hai Chen, MDPrincipal Investigator

Sites

1 total
Hong Kong, Hong Kong

Facts & assertions

3 sourced
Enrollment
169
Phase
PHASE4
Status
COMPLETED
relationships
The graph out of here
drug
Quetiapine
drug
lead_sponsor
The University of Hong Kong
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Eric Yu Hai Chen, MD
person